News-Medical.Net March 26, 2025
Dr. Liji Thomas, MD

A new rapid review finds that full vaccination may reduce the odds of post-COVID-19 condition (PCC) by 27%, though more research is needed—especially in children and immunocompromised groups.

A recent rapid review published by the European Center for Disease Prevention and Control (ECDC) explores the benefit of vaccination in avoiding or shortening adverse events following acute infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Introduction

The coronavirus disease 2019 (COVID-19) pandemic shook global healthcare systems, with hundreds of millions of cases and over seven million deaths over less than three years.

The rapid development and rollout of the nucleic acid vaccine against this virus led to a marked reduction in the risk of severe illness and death following...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Provider, Public Health / COVID, Survey / Study, Trends
While others moved on, long COVID-19 changed 'the trajectory' of these women's lives
Artificial intelligence tool predicts virus outbreak hotspots
‘This is all wholly preventable,’ former Covid chief says of measles outbreak
Unlocking the Potential: Medication Assisted Therapies for Opioid Substance Use Disorder in Correctional Settings
US measles cases on track to double 2024 tally: 6 updates

Share This Article